2ϩ -regulated K ϩ channels are involved in numerous Ca 2ϩ -dependent signaling pathways. In this study, we investigated whether the Ca 2ϩ -activated K ϩ channel of intermediate conductance SK4 (KCa3.1, IK1) plays a physiological role in pancreatic ␤-cell function. RESULTS-SK4-KO mice showed improved glucose tolerance, whereas insulin sensitivity was not altered. The animals were not hypoglycemic. Isolated SK4-KO ␤-cells stimulated with 15 mmol/l glucose had an increased Ca 2ϩ action potential frequency, and single-action potentials were broadened. These alterations were coupled to increased [Ca 2ϩ ] c . In addition, glucose responsiveness of membrane potential, [Ca 2ϩ ] c , and insulin secretion were shifted to lower glucose concentrations. SK4 protein was expressed in WT islets. An increase in K ϩ currents and concomitant membrane hyperpolarization could be evoked in WT ␤-cells by the SK4 channel opener DCEBIO (100 mol/l). Accordingly, the SK4 channel blocker TRAM-34 (1 mol/l) partly inhibited K Ca currents and induced electrical activity at a threshold glucose concentration. In stimulated WT ␤-cells, TRAM-34 further increased [Ca 2ϩ ] c and broadened action potentials similar to those seen in SK4-KO ␤-cells. SK4 channels were found to substantially contribute to K slow (slowly activating K ϩ current).
S
K4 channels are Ca 2ϩ -activated K ϩ channels of intermediate conductance (synonymous with IK1 and KCa3.1) encoded by the KCNN4 gene. They are primarily expressed in cells of the hematopoietic system, where they represent the Gardos channel (1) . Channel activation requires Ca 2ϩ increase and determines the cell volume of T-cells and erythrocytes by elevating K ϩ efflux. In organs regulating salt and fluid transport (e.g., colon, salivary glands, and lung), SK4 current provides the driving force for secondary electrogenic ion transport (2) (3) (4) . SK4 channels are suggested to be involved in mast cell stimulation (5) , and channel upregulation is important for lymphocyte activation and cell proliferation (6, 7) . For enteric neurons, SK4 channels seem to mediate the late after-hyperpolarization (8) . In 1997, SK4 channels were cloned from human pancreatic tissue (9) . A detailed investigation of mRNA and protein expression of K Ca channels of intermediate (SK4) and small conductance (SK1-3) was performed by Tamarina et al. (10) showing mRNA expression of these channels in murine islets.
In the past, ATP-sensitive K ϩ (K ATP ) channels were considered to be essential for glucose homeostasis. Consequently, K ATP channel inhibitors are important drugs to augment insulin secretion in type 2 diabetic subjects. However, with the generation of two K ATP channeldeficient mouse models (SUR1 and Kir6.2 knockout), it was shown that K ATP channels are not indispensable for glycemic control (11) (12) (13) (14) . Neither SUR1 nor Kir6.2 knockout mice show severe hypoglycemia or any symptoms of insulin hypersecretion. Several reports provide evidence that efficient blood glucose regulation and even glucosedependent insulin secretion (15) (16) (17) is possible despite K ATP channel ablation. In the search for compensatory mechanisms, modulation of insulin release by other K ϩ channels gains particular interest.
Besides K Ca channels, pancreatic ␤-cells express K ϩ channels exclusively regulated by voltage (K v channels) (10, 18, 19) . Several studies indicate that K v channel activation plays a role in action potential (AP) repolarization (20 -22) . Blocking these channels broadens APs and increases insulin secretion (23) (24) (25) . Recently, it was shown that K v 2.1 ablation drastically reduces K v currents of isolated ␤-cells (26) . Interestingly, this coincides with improved glucose tolerance pointing to a specific role for K v 2.1 in the regulation of insulin secretion. For decades, it was discussed whether K Ca channels participate in the regulation of ␤-cell activity (27) . An early report (28) described K Ca currents that were periodically activated by inositol-trisphosphate-dependent Ca 2ϩ mobilization. The existence of large conductance K Ca channels (BK channels) in pancreatic ␤-cells and insulin-secreting cell lines has been verified by several groups (29 -31) . However, since blockage of BK channels does not alter membrane potential oscillations (31, 32) , these channels are not considered to play a major role in glucosestimulated insulin release. In 1999, a K ϩ current activating with increasing Ca 2ϩ influx during burst phases of glucosestimulated ␤-cells was detected (33) . The current, termed K slow because of its delayed and slow onset, strongly depends on [Ca 2ϩ ] c . Further analysis suggested that ϳ50% could be ascribed to K ATP current (34) . However, the remaining sulfonylurea-insensitive component of K slow does not resemble the characteristics of any known K Ca channel (33) , and its precise nature remains to be identified. It has been suggested that K Ca channels of small conductance (SK1-3) play a functional role in ␤-cells (10, 35) , but at present, there is only limited information about their contribution to glucose handling of the whole organism.
Because up to now nothing is known about the significance of SK4 channels in pancreatic ␤-cells, this study was performed to elucidate whether SK4 channels are suitable candidates for modulation of ␤-cell function. We demonstrate that SK4 channels are expressed in murine islets and investigated the influence of constitutive SK4 channel knockout (SK4-KO) and of pharmacological SK4 channel inhibition on glucose homeostasis, insulin sensitivity, and the stimulus-secretion cascade of murine pancreatic ␤-cells.
RESEARCH DESIGN AND METHODS
Animals and cell and islet preparation. Experiments were performed with SK4-KO and wild-type (Sv129/C57Bl6 or C57Bl/6) mice. The principles of laboratory animal care were followed (NIH publication number 85-23, revised 1985) , and experiments were carried out according to German laws (Regierungsprä sidium Stuttgart, Germany, approval number PZ 1/08). SK4-KO mice were generated as previously described (5) . In brief, the targeting vector was constructed by flanking the pore exon by a single loxP site and a floxed neo/tk cassette. Correctly targeted L1/ϩ clones were injected into C57Bl6 blastocysts. Resulting chimeras were mated with Sv129 mice to obtain germ-line transmission. Heterozygous offspring were intercrossed with C57Bl6 mice, yielding a Sv129/C57Bl6 hybrid background. For in vitro experiments, mice were killed with CO 2 , and islets were isolated by collagenase digestion. Islets were dispersed in Ca 2ϩ -free medium and cultured for up to 4 days in RPMI-1640 medium (11.1 mmol/l glucose) supplemented with 10% FCS, 100 units/ml penicillin, and 100 g/ml streptomycin. was adjusted to 10 mol/l by CaCl 2 . Incubation medium for insulin secretion was as follows (in mmol/l): 122 NaCl, 4.8 KCl, 2.5 CaCl 2 , 1.1 MgCl 2 , 10 HEPES, and 0.5% BSA, pH 7.4. Lysis buffer for Western blot included the following (in mmol/l): 125 NaCl, 1% Triton X-100, 0.5% Na-deoxycholate, 0.1% SDS, 10 EDTA, 25 HEPES, 10 NaPP, 10 NaF, 1 Na-vanadate, and protease inhibitor cocktail (Roche), pH 7.3.
Fura-2AM was obtained from Molecular Probes (Eugene, OR). RPMI-1640 medium was from PromoCell (Heidelberg, Germany) and penicillin/streptomycin from GIBCO/BRL (Karlsruhe, Germany). All other chemicals were purchased from Sigma (Deisenhofen, Germany) and Merck (Darmstadt, Germany). Glucose tolerance and insulin sensitivity. In vivo experiments were performed with male SK4-KO mice and WT littermates aged 12, 24, and 36 weeks. Glucose (2 g/kg body wt) or insulin (0.7 IU/kg body wt) was injected intraperitoneally. Changes in plasma glucose concentration were monitored for 120 or 60 min, respectively. Mice were fasted for 16 h before glucose tolerance testing. Measurement of [Ca 2؉ ] c . [Ca 2ϩ ] c was measured in single cells or small clusters by the fura-2 method (36) using equipment and software from TILL photonics (Grä felfing, Germany). Cells were identified as ␤-cells when [Ca 2ϩ ] c was not decreased by 15 mmol/l glucose as described for ␣-cells (37) . Cells were loaded with fura-2AM (5 mol/l) for 30 min at 37°C. Fura-2 was excited alternately at 340 or 380 nm. The emitted light was filtered (LP515 nm) and measured by a digital camera. [Ca 2ϩ ] c was calculated after an in vitro calibration with fura-2 K ϩ salt (36) . Electrophysiology. Patch pipettes were pulled from borosilicate glass capillaries (Clark, Pangbourne, U.K.). V m was recorded at 32°C with an EPC-9 patch-clamp amplifier (HEKA, Lambrecht, Germany). K ϩ currents were elicited by 10 mV voltage steps (300 ms) from a holding potential of Ϫ70 mV. K slow currents were determined according to the methodology of Gö pel et al. (33): after a 30-mV depolarizing step, a train of 26 voltage ramps (Ϫ40 to 0 to Ϫ40 mV within 200 ms) was applied and followed by at least 10 s at Ϫ40 mV before the voltage step back to Ϫ70 mV. Data were analyzed with "Chart" software (ADInstruments, Spechbach, Germany). Inside-out recordings were performed at a holding potential of Ϫ50 mV. Insulin secretion. Batches of five islets were incubated for 60 min at 37°C. Insulin was determined by radioimmunoassay using rat insulin (Linco Research, St. Charles, MO) as the standard. Western blot analysis. For determination of SK4 channel protein, ϳ300 islets per genotype were collected, rinsed with PBS, and homogenized in lysis buffer (see above). Protein amount was determined by a Bradford assay. The homogenates (100 g per lane) were separated on a 12.5% SDS-PAGE. Peptides were blotted on a polyvinylidene difluoride membrane. The primary antibody was directed against the COOH-terminus of SK4 (1:200; Santa Cruz Technology, Santa Cruz, CA). PKB was used as loading control (1: 
is the probability of glucose-induced stimulation, D 50 is the dose level with 50% response probability, D is the glucose concentration (in mmol/l), and c reflects the slope of the concentration-response curve. The equation was adjusted by a maximum-likelihood procedure. A P value of Ͻ0.05 was considered significant.
RESULTS
Role of SK4 channels in glucose-induced stimulussecretion coupling. To elucidate whether SK4 channels interact with ␤-cell function, we tested whether knockout of SK4 channels influences ␤-cell activity in response to glucose. SK4-KO was accompanied by several alterations in glucose responsiveness ( Fig. 1C ). These data show that in SK4-KO ␤-cells, the elevated electrical activity is paralleled by Ca 2ϩ influx. Influence of pharmacological modulation of SK4 channels on ␤-cell function. To test whether druginduced alterations of SK4 channel activity influences ␤-cell stimulus-secretion coupling, the SK4 channel blocker TRAM-34 (38) was investigated for effects on electrical activity and [Ca 2ϩ ] c . In stimulated ␤-cells, the SK4 channel inhibitor induced similar changes in the shape of Ca 2ϩ APs, as observed in SK4-KO ␤-cells (compare Fig. 1B and D) . TRAM-34 (1 mol/l) elevated the width at half-maximum amplitude from 19 Ϯ 4 to 29 Ϯ 3 ms (n ϭ 5, P Յ 0.05), and the plateau potential was shifted from Ϫ51 Ϯ 1 to Ϫ47 Ϯ 1 mV (n ϭ 5, P Յ 0.05). Importantly, [Ca 2ϩ ] c was also modulated by blocking SK4 channels (Fig. 1E ). In this series of experiments, 1 mol/l TRAM-34 was added to ␤-cells stimulated with 11.1 mmol/l glucose. Acute application of the SK4 channel blocker abrogated the oscillatory pattern of [Ca 2ϩ ] c that characterizes glucose-stimulated ␤-cells (39) and clearly augmented [Ca 2ϩ ] c . Quantification of the AUC Ca for 4 min before changes in the bath solution showed that TRAM-34 increased the AUC Ca 1.8-fold vs. control conditions (i.e., ⌬ of 22 Ϯ 3 mol/l min, n ϭ 5, P Յ 0.001). For specificity testing, SK4-KO ␤-cells were also treated with TRAM-34, yielding a slight change in the pattern of oscillations but no increase in [Ca 2ϩ ] c . On average, the AUC Ca in G11.1 was 21 Ϯ 4 mol/l min without and 25 Ϯ 5 mol/l min with 1 mol/l TRAM-34, respectively (i.e., ⌬ of 5 Ϯ 2 mol/l min, n ϭ 5, NS vs. control, not shown). Next, the effect of DCEBIO, a potent SK4 channel activator (40) , was investigated. In agreement with activation of a K ϩ current, DCEBIO (100 mol/l) rapidly hyperpolarized V m ( Fig. 2A) . This series of experiments was performed in the presence of high glucose (15 mmol/l), tolbutamide (1 mmol/l), and nifedipine (5 mol/l) to exclude any influence of K ATP and Ca 2ϩ currents. [Ca 2ϩ ] c was elevated by 1 mol/l ionomycin. On average, V m was altered from Ϫ37 Ϯ 2 to Ϫ56 Ϯ 4 mV after addition of DCEBIO (n ϭ 7, P Յ 0.001). The K ϩ current elicited by a 10-mV depolarizing voltage step (from Ϫ70 to Ϫ60 mV) amounted to 3.61 Ϯ 0.51 pA in the presence of DCEBIO and was reduced to 1.60 Ϯ 0.17 pA after washout (n ϭ 5, P Յ 0.01). DCEBIO is not entirely specific for SK4 channels and has been reported to interact with Ca 2ϩ and Cl Ϫ channels (40 -42) . Therefore, we performed analogical experiments with SK4-KO ␤-cells (Fig. 2B) . V m was Ϫ38 Ϯ 3 mV under control conditions and Ϫ33 Ϯ 3 mV after addition of DCEBIO (n ϭ 13), strongly suggesting that the hyperpolarization in WT ␤-cells was in fact due to SK4 channel activation. To directly show that SK4 channels are present in ␤-cells, we performed inside-out single-channel measurements (Fig. 2C) . Besides BK and SK channels, we identified a K Ca channel with a single channel conductance of 39 Ϯ 1 pS (n ϭ 5), fitting with the properties of SK4 channels in other tissues (43, 44) . The expression of SK4 protein was confirmed in isolated WT islets by Western blot analysis (Fig. 2D, left) . Specificity of the antibody was confirmed by the absence of immunostaining in SK4-KO islets (Fig. 2D, right) . These data demonstrate that SK4 channels are operative in ␤-cells and that pharmacological modulation influences glucose-induced stimulus-secretion cascade. Contribution of SK4 channels to K slow currents. To test whether SK4 channels contribute to the Ca 2ϩ -regulated component of K slow , ␤-cells were stimulated with 15 mmol/l glucose, and a pulse protocol similar to that described by Gö pel et al. (33, 34) was used to imitate a burst of Ca 2ϩ APs (Fig. 2E, upper trace) . The increase in current amplitude induced by a train of 26 voltage ramps was quantified in the absence and presence of TRAM-34 (Fig. 2E, lower trace, left and middle) . The current elicited by this protocol was significantly reduced by TRAM-34 (compare arrows and areas marked by the dashed lines). K slow was 13.3 Ϯ 2.1 pA under control conditions and 8.2 Ϯ 1.2 pA with 1 mol/l TRAM-34 (n ϭ 7, P Յ 0.01). After washout, the current increased to 13.5 Ϯ 2.3 pA (n ϭ 7, NS vs. control). As SK4 channels have been reported to be sensitive to charybdotoxin, a scorpion toxine widely used to block BK channels (45), we tested whether K slow was 
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affected by this drug. Up to 100 nmol/l charybdotoxin had no inhibitory effect on K slow (n ϭ 4, not shown). To further elucidate the involvement of SK4 channels in generation of K slow , the above-mentioned protocol was applied to SK4-KO ␤-cells (Fig. 2E, right) . SK4 ablation significantly reduced K slow . In this series of experiments, the current averaged 10.3 Ϯ 1.8 pA in WT (n ϭ 11) and 3.6 Ϯ 0.8 pA in SK4-KO ␤-cells (n ϭ 5, P Յ 0.05). Tolbutamide (1 mmol/l) did not completely abolish but further reduced K slow (2.1 Ϯ 0.3 pA, n ϭ 5, NS compared with control conditions without sulfonylurea) in SK4-KO ␤-cells. These data clearly show that a significant component of K slow is carried by SK4 channels. Lack of SK4 channels leads to a left shift in glucose responsiveness. Neither SK4-KO nor TRAM-34 influenced the resting membrane potential, which was Ϫ77 Ϯ 1 mV in 0.5 mmol/l glucose and Ϫ76 Ϯ 1 mV with TRAM-34 (1 mol/l, n ϭ 3) compared with Ϫ75 Ϯ 1 mV in SK4-KO ␤-cells (n ϭ 7, not shown). To find out whether ablation of SK4 channels affects glucose responsiveness, we investigated whether stimulation of SK4-KO ␤-cells was shifted to lower glucose concentrations. Cells were perifused with bath solution containing 6 or 8 mmol/l glucose. In WT ␤-cells, no electrical activity was observed with 6 mmol/l glucose (n ϭ 7), whereas 37.5% of the cells were depolarized and Ca 2ϩ APs occurred with 8 mmol/l glucose (n ϭ 8). By contrast, in SK4-KO mice, 63.6% of the ␤-cells were already stimulated by 6 mmol/l glucose (n ϭ 11) and all cells (100%) by 8 mmol/l glucose (n ϭ 5) (Fig. 3A) . Consistent with the higher fraction of electrically active ␤-cells, we observed a significant left shift of the glucose concentration-response curve of [Ca 2ϩ ] c in SK4-KO versus WT ␤-cells (Fig. 3B) . In these experiments, isolated ␤-cells were perifused with bath solutions containing 0.5-15 mmol/l glucose. Cells were considered to be glucose responsive if they displayed an increase in [Ca 2ϩ ] c and/or Ca 2ϩ oscillations. The D 50 value (50% probability for glucose responsiveness) was 6.37 mmol/l (95% CI 6.09 -6.68) for WT ␤-cells and was reduced to 5.67 mmol/l (5.29 -6.05) for SK4-KO ␤-cells. SK4-KO also affected insulin secretion. Islets were incubated in 3, 6, or 8 mmol/l glucose for 60 min. WT and SK4-KO islets had similar insulin content (WT: 29 Ϯ 3 ng/islet; SK4-KO: 29 Ϯ 1 ng/islet, n ϭ 8 different preparations for both genotypes), and there was no significant change in insulin release under basal conditions ( ( Fig. 3C) . These data clearly demonstrate that genetic ablation of SK4 channels sensitizes the ␤-cells to glucose stimulation.
Importantly, SK4 channel inhibition induced similar changes in WT ␤-cells (Fig. 3D) . In this series of experiments, WT and SK4-KO ␤-cells, respectively, were perifused with 10 mmol/l glucose before lowering glucose below the threshold for Ca 2ϩ APs (5-6 mmol/l glucose). After addition of TRAM-34 (1 mol/l) to WT ␤-cells, electrical activity occurred in four of five cells. On average, V m was Ϫ67 Ϯ 2 mV at the subthreshold glucose concentration. With TRAM-34, the plateau potential at which Ca 2ϩ APs started was Ϫ51 Ϯ 1 mV (n ϭ 5, P Յ 0.001). In SK4-KO ␤-cells, 1 mol/l TRAM-34 had no depolarizing effect on V m (Fig. 3E) . In this series of experiments, V m was Ϫ67 Ϯ 2 mV after lowering glucose to a concentration terminating electrical activity and Ϫ67 Ϯ 1 mV in the presence of TRAM-34 (n ϭ 3).
Knockout of SK4 channels affects glucose tolerance in vivo. Because the experiments described thus far suggest that SK4 channels participate in regulation of glycemic control, we investigated whether ablation of SK4 channels affects glucose homeostasis in vivo. Therefore, an intraperitoneal glucose tolerance test was performed on 12-week-old male WT and SK4-KO mice. After injection of 2 g glucose/kg body wt, blood glucose was monitored during 120 min. SK4-KO mice had significantly lower blood glucose concentrations than WT mice (Fig. 4A and Table 1) . By contrast, blood glucose concentrations in the fasted and fed state were similar in WT and SK4-KO mice, respectively ( Table 1) .
The improved glucose tolerance of SK4-KO mice might not exclusively represent a better secretory response of pancreatic ␤-cells but could also result from improved insulin sensitivity. To address this question, 0.7 IU insulin/kg body wt was injected intraperitoneally, and the decrease of blood glucose concentration was followed for 60 min (Fig. 4B and Table 1 ). Insulin sensitivity of SK4-KO mice was not different from their WT littermates (n ϭ 5-6). To test whether these results were influenced by age, glucose and insulin tolerance tests were repeated with 24-week-old animals (n ϭ 5-6; data are summarized in Table 1 ). Even in older animals (ϳ36 weeks), the beneficial effects of SK4-KO on glucose homeostasis still persisted (blood glucose concentration 2 h after glucose injection in WT animals: 8.7 Ϯ 0.7 mmol/l, n ϭ 8; in SK4-KO mice: 6.5 Ϯ 0.2 mmol/l, n ϭ 8, P Յ 0.01). These experiments demonstrate that SK4-KO ameliorates glycemic control independent of age. To make sure that the improved secretory response of SK4-KO mice was not accompanied by ␤-cell exhaustion, we determined the insulin content in islets from animals at different ages (up to 9 months). These experiments confirmed that insulin content did not change with age (4.5-5.5 months: WT 25 Ϯ 6 ng/islet vs. KO 25 Ϯ 5 ng/islet, n ϭ 3 different preparations per genotype; 6 -7 months: WT 26 Ϯ 3 ng/islet, n ϭ 5, vs. KO 27 Ϯ 2 ng/islet, n ϭ 3; 8 -9 months: WT 34 Ϯ 5 ng/islet, n ϭ 2, vs. KO 28 Ϯ 2 ng/islet, n ϭ 4; NS vs. WT, NS vs. ϳ5-month-old mice).
DISCUSSION
Our experiments show for the first time that SK4 channels participate in the regulation of ␤-cell function and glucose homeostasis in vivo. Glucose-induced insulin secretion involves tight coupling of glucose metabolism, electrical activity, [Ca 2ϩ ] c , and exocytosis. The key event linking glucose metabolism to membrane depolarization is the closure of K ATP channels. Subsequent opening of L-type Ca 2ϩ channels increases [Ca 2ϩ ] c , representing the triggering signal for insulin release (46, 47) . Our data show that SK4 channel protein is expressed in murine pancreatic islets. SK4 channels are operative in ␤-cells and constitute an important regulator of stimulus-secretion coupling. In WT ␤-cells, pharmacological opening or closure of SK4 channels crucially alters V m (Figs. 2 and 3D ). Importantly, the SK4 channel blocker TRAM-34 depolarizes V m and induces electrical activity at a subthreshold glucose concentration, thus enhancing the glucose effect on stimulus-secretion coupling (Fig. 3D) . This is of considerable significance, since it demonstrates that SK4 channels contribute to regulation of insulin release in the narrow range around the threshold blood glucose concentration physiologically relevant for glycemic control. In addition, TRAM-34 and SK4-KO significantly reduce K slow currents that are thought to participate in the characteristic burst pattern of pancreatic ␤-cells. Our observation that SK4 is one component of K slow (Fig.  2E ) emphasizes the importance of the SK4 channel for ␤-cell electrical activity. Although the involvement of SK4 in K slow generation is evidenced by the reduced current in SK4-KO ␤-cells and in TRAM-34 -treated WT cells, charybdotoxin failed to affect K slow . This observation requires further investigation but is in agreement with reports of others (33) describing inefficiency of the scorpion toxin on K slow or on whole-cell currents with SK4 characteristics (48) . Importantly, the typical oscillations of glucose-stimulated ␤-cells are not prevented by SK4-KO, and K slow is not completely absent in SK4-KO ␤-cells, even in the presence of 1 mmol/l tolbutamide. This suggests, in agreement with what has previously been proposed by Kanno et al. (34) , that K ATP channels, SK4, and other K Ca channels act in concert to regulate the bursting activity of pancreatic ␤-cells.
SK4-KO did not affect blood glucose concentration of fed or fasted mice, demonstrating that glucose homeostasis can be maintained by other factors, e.g., adaptation in central regulation of energy balance or activation of peripheral counterregulatory mechanisms. However, SK4-KO improved the glucose tolerance after glucose challenge, whereas insulin sensitivity remained unchanged (Fig. 4) . This strongly suggests that the ␤-cell is the major target of SK4-KO with regard to glycemic control. Indeed, SK4-KO ␤-cells displayed alterations in agreement with improved glucose tolerance: in glucose-stimulated SK4-KO ␤-cells, the plateau potential was more depolarized compared with WT cells. Consequently, the frequency of Ca APs was increased by ϳ30%. In addition, loss or blockade of SK4 channels resulted in AP broadening and elevated Ca 2ϩ influx. These effects are suited to enhance exocytosis and finally to improve glucose tolerance.
For control of insulin secretion, the concentrationresponse correlation of glucose and electrical activity is very important (49) . SK4-KO induced a clear left shift in glucose responsiveness with respect to V m , [Ca 2ϩ ] c , and insulin secretion (Fig. 3A-C) . Furthermore, electrical activity could be induced by TRAM-34 applied to subthreshold glucose concentrations, i.e., when V m is already depolarized but has not reached the threshold for Ca 2ϩ APs (Fig. 3D) . It is well-known that the resting membrane potential of ␤-cells is predominantly carried by K ATP current (50, 51) . In agreement, SK4-KO did not affect the responsiveness of ␤-cells at low glucose concentrations (Fig. 3B) and TRAM-34 did not depolarize WT ␤-cells under resting conditions. Regulation of insulin secretion occurs via a gradual decrease in the open probability of K ATP channels in response to a stepwise elevation of glucose (46) , thereby increasing membrane depolarization. SK4 channel opening is largely independent of V m (2, 52) but strictly regulated by [Ca 2ϩ ] c . Half-maximal activation occurs at Ca 2ϩ concentrations ranging from 300 to 500 nmol/l (53). For myocytes, it has been shown that SK4 channels are already open when Ca 2ϩ is reduced below 100 nmol/l (52). This is in agreement with our observation that SK4 channel inhibition influences V m under conditions where [Ca 2ϩ ] c is in the low nanomoles per liter range. For pancreatic ␤-cells, it was suggested that Ca 2ϩ influx via L-type Ca 2ϩ channels does not increase at a V m below Ϫ40 mV (54) . This might raise the question why SK4 channel inhibition does not affect V m at 0.5 mmol/l glucose but initiates APs at 6 mmol/l glucose. However, because Larsson-Nyré n et al. (54) induced Ca 2ϩ influx by short depolarizing voltage steps starting at Ϫ70 mV, they cannot elucidate whether a gradual increase of V m elevates Ca 2ϩ channel activity, thereby promoting Ca 2ϩ influx even below the threshold for Ca 2ϩ APs. In this context, it is noteworthy that Nelson et al. (55) demonstrated in cellattached membrane patches of basilar arteries that the open probability of L-type Ca 2ϩ channels already starts to increase at Ϫ65 mV, which is ϳ20 mV more negative than the threshold potential for APs. Consequently, glucoseregulated membrane depolarization might enhance SK4 channel activity dose dependently even before the threshold for induction of Ca 2ϩ APs. Our data suggest that membrane depolarization induced by closure of K ATP channels leads to Ca 2ϩ influx and subsequent activation of SK4 channels. This mechanism counteracts the depolarization and promotes closure of L-type Ca 2ϩ channels. We hypothesize that modulation of ␤-cell activity via SK4 channels contributes to the precise adjustment of insulin secretion according to the current metabolic demands. An important regulatory function of SK4 channels concerning intracellular Ca 2ϩ homeostasis has also been described for other cellular systems. In mast cells or in the endothelium, receptor-mediated Ca 2ϩ influx activates SK4 channels, thereby inducing membrane hyperpolarization. However, in contrast to pancreatic ␤-cells, the increased K ϩ conductance enforces Ca 2ϩ influx in these cells through transient receptor potential or store-operated Ca 2ϩ channels. The final result is elevation of [Ca 2ϩ ] c , which triggers mast cell degranulation or endothelium-mediated vasodilation, respectively (5, 56) . Depending on the pathway of Ca 2ϩ influx, SK4 channel activation could either enhance or limit Ca 2ϩ -regulated signaling cascades in different tissues or organs.
As the Ca 2ϩ dependence of SK4 channels is expected to couple channel activity to the metabolic status of pancreatic ␤-cells, SK4 channels may modulate cell function without bearing the risk for unwanted hypoglycemic episodes, which complicates the use of insulinotropic drugs acting on K ATP channels (57, 58) . Importantly, SK4-KO mice displayed no signs of hypoglycemia after overnight fasting or when they were fed ad libitum, which shows that the genetic manipulation did not result in excessive insulin secretion per se but improved ␤-cell response when challenged with high blood glucose concentrations. Because SK4-KO markedly elevated the proportion of active ␤-cells, it is suggested that a reduction of the SK4 current is a suitable tool to recruit more ␤-cells for nutrient-stimulated insulin release. Thus, targeting SK4 channels pharmacologically might be a useful approach to augment insulin release in ␤-cells with impaired secretory response.
